<DOC>
	<DOCNO>NCT01060878</DOCNO>
	<brief_summary>A study test therapeutic benefit compound PYM50028 , versus placebo , treat early-stage Parkinson 's disease . Therapeutic benefit assess use Unified Parkinson 's Disease Rating Scale ( UPDRS ) . It hypothesise PYM50028 safe well tolerate study demonstrate therapeutic benefit patient population .</brief_summary>
	<brief_title>Investigation Cogane ( PYM50028 ) Early-stage Parkinson 's Disease ( CONFIDENT-PD )</brief_title>
	<detailed_description />
	<mesh_term>Parkinson Disease</mesh_term>
	<criteria>confirm diagnosis earlystage idiopathic PD within 2 year prior screen subject currently receive PD treatment female childbearing potential history neurosurgical procedure PD history severe psychiatric illness</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>March 2013</verification_date>
	<keyword>Early-stage</keyword>
</DOC>